Exercise of Options and Total Voting Rights

Summary by AI BETAClose X

Calnex Solutions PLC has issued 82,300 new ordinary shares following the exercise of options under its equity incentive schemes, with admission to trading on AIM expected around June 3, 2026. This issuance will increase the company's total issued share capital to 88,073,936 ordinary shares, which shareholders can use as a denominator for calculating their notification requirements under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Disclaimer*

Calnex Solutions PLC
29 May 2026
 

Calnex Solutions plc

 

("Calnex" or the "Company")

 

Exercise of Options and Total Voting Rights

 

Calnex Solutions plc (AIM: CLX), a leading provider of test and measurement solutions for the global telecommunications and cloud computing markets, announces that the Company has issued a total of 82,300 new ordinary shares of 0.125 pence each ("New Shares"), pursuant to the exercise of options issued under the Company's equity incentive schemes.

 

Application has been made for the admission of the New Shares to trading on AIM ("Admission"). The New Shares will rank pari passu with the existing Ordinary Shares and it is expected that Admission will become effective on or around 8.00 a.m. on 3 June 2026.

 

Following Admission, the Company's issued share capital will consist of 88,073,936 Ordinary Shares with voting rights. Calnex does not hold any Ordinary Shares in treasury. This figure of 88,073,936 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they require to notify their interest in, or a change to their interest in, the share capital of the Company under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

For more information, please contact:

Calnex Solutions plc

Via Alma

Tommy Cook, Chief Executive Officer

Ashleigh Greenan, Chief Financial Officer







Cavendish Capital Markets Limited - NOMAD

+44 (0)131 220 6939

Derrick Lee, Peter Lynch



 



Alma Strategic Communications

+ 44(0) 20 3405 0213

Caroline Forde, Joe Pederzolli, Emma Thompson


 

Overview of Calnex

Calnex Solutions designs, produces and markets innovative test and measurement instrumentation that enables customers to validate the performance of critical network technologies and applications. Our solutions support customers from R&D and pre‑deployment through to in‑service testing, providing confidence that networks and applications operate as intended in increasingly complex and performance‑critical environments.

 

To date, Calnex has secured and delivered orders in 68 countries across the world. Customers include BT, China Mobile, NTT, Ericsson, Nokia, Intel, Qualcomm, IBM, Nvidia and Meta.

 

Founded in 2006, Calnex is headquartered in Linlithgow, Scotland, with additional locations in Belfast, Northern Ireland, Stevenage, England and California in the US, supported by sales teams in China and India. Calnex has a global network of partners, providing worldwide distribution and market access. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings